U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number 0-18785
[X] Form 10-QSB
For Period Ended: March 31, 1999
Nothing in this Form shall be construed to imply that the
Commission has verified any information contained herein.
PART I - REGISTRANT INFORMATION
Full Name of Registrant: Oxboro Medical International, Inc.
Former Name if Applicable: Not Applicable
Address of Principal Executive Office:
13828 Lincoln Street NE
Ham Lake, MN 55304
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort
or expense and the Registrant seeks relief pursuant to Rule 12b-
25(b), the following should be completed.
(check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense;
[X] (b) The subject quarterly report on 10Q-SB, or portion thereof
will be filed on or before the fifth calendar day
following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why the Form 10-QSB
could not be filed within the prescribed time period:
The Registrant had a regularly scheduled Board meeting set for
Tuesday, May 18, 1999. However, the Registrant determined that,
contrary to original expectations, the Board needed to review the
language of the Form 10-QSB and a related press release before they
could be filed or released. Because of prior commitments, the Board
could not meet on Monday, May 17, 1999, and it would have been a
disproportionately large expense and effort (as well as serious
interference with numerous schedules) for the Board to meet on
either Friday, May 14, 1999, or Saturday May 15, 1999.
The extra time and effort needed by the Registrant's Board could not
be eliminated without unreasonable effort or expense.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to
this notification:
Matthew E. Bellin 612-755-9516
(Name) (Telephone No.)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of
the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the Regisrant was
required to file such report(s) been filed? If the answer
is no, identify report(s). [x] Yes
[ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[x] Yes
[ ] No
If so: Attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results can not be
made.
EXPLANATION: Registrant reported net losses of ($109,616) and
($21,005), respectively, for its comparable quarter and six month
periods ended March 31, 1998. For the fiscal quarter and six month
periods ended March 31, 1999, the Registrant expects to report a
sizeable loss, the exact dimensions of which have yet to be approved
by the Board. (The Registrant reported a net loss of ($47,459) for
its interim, three month period ended December 31, 1998.)
SIGNATURES
Oxboro Medical International, Inc. has caused this notification to be
signed on its behalf by the undersigned thereunto duly authorized.
OXBORO MEDICAL INTERNATIONAL, INC.
Date: May 18, 1999 By /s/ Matthew E. Bellin
-----------------------------
Matthew E. Bellin
Its President
INSTRUCTION: The Form may be signed by an executive officer of the
Registrant or by any other duly authorized representative. The name and
title of the person signing the Form shall be typed or printed beneath
the signature.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
